LabCorp Services - Cardiology

Cardiovascular Disease Evaluating hemostasis has always been a critical part of laboratory testing. And now with the new thrombotic test markers, overall testing is even more important for the well being of our patients.

Cardiovascular diseases, mainly heart disease and stroke, are among the nation's leading causes of death in both men and women. LabCorp offers an extensive portfolio of routine and esoteric assays to assist physicians in the diagnosis, treatment, and monitoring of cardiovascular disorders.

Choices in Testing for Complete Cardiovascular Care

Traditional methods and emerging markers to assist physicians in risk assessment, diagnosis and monitoring.

Expanded Lipid Profiles Identify patients at increased risk for heart disease who may be missed using traditional lipid testing

NMR LipoProfile^®

The VAP^® Cholesterol test
The PLAC® test for stroke and heart attack risk assessment

The PLAC^® test flyer

The PLAC^® test brochure
Introduction to Hemostasis and ThrombosisThese Web pages provide a basic overview of hemostasis and thrombosis with particular focus on the role of the clinical laboratory. Includes an interactive coagulation cascade and lupus testing cascade.
Hypertension, often referred to as high blood pressure, directly kills more than 40,000 Americans per year and is a contributing factor in more than 200,000 deaths.

Hypertension and the Clinical Lab
Hereditary hemochromatosis (HH) is an autosomal recessive iron storage disorder. Despite sufficient stores of iron in the body, people with HH absorb more iron than is necessary, leading to an iron overload that is damaging to most tissues. Confirmatory testing options include histologic assessment of iron stores via liver biopsy and DNA testing for the genetic mutations associated with HH.

Hereditary Hemochromatosis, DNA Analysis

High-sensitivity C-Reactive Protein (hs-CRP) C-reactive protein (CRP) is synthesized by the liver and its blood level serves as a marker for inflammation. Using CRP as a marker for vascular inflammation has been impractical for years because existing assays lacked the required sensitivity to measure low concentrations of CRP reliably. However, with the recent development of high sensitivity assays (hs-CRP), several clinical studies have confirmed CRP as an independent risk factor for coronary heart disease (CHD) as well as peripheral vascular disease, another form of cardiovascular disease (CVD).

High-sensitivity C-Reactive Protein (hs-CRP)

Lipoprotein (a) has been called a powerful predictor of premature atherosclerotic vascular disease*.

Lipoprotein (a)

*Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Int Med. 1997; 157:1170-1176.

LabCorp's Ambulatory Monitoring Services (AMS) provides the medical community with expertise in ambulatory cardiovascular testing. For more information on AMS.

Top of Page